These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 33919660)

  • 1. Drug Repurposing for COVID-19 Treatment by Integrating Network Pharmacology and Transcriptomics.
    Liu DY; Liu JC; Liang S; Meng XH; Greenbaum J; Xiao HM; Tan LJ; Deng HW
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33919660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network bioinformatics analysis provides insight into drug repurposing for COVID-19.
    Li X; Yu J; Zhang Z; Ren J; Peluffo AE; Zhang W; Zhao Y; Wu J; Yan K; Cohen D; Wang W
    Med Drug Discov; 2021 Jun; 10():100090. PubMed ID: 33817623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DTSEA: A network-based drug target set enrichment analysis method for drug repurposing against COVID-19.
    Su Y; Wu J; Li X; Li J; Zhao X; Pan B; Huang J; Kong Q; Han J
    Comput Biol Med; 2023 Jun; 159():106969. PubMed ID: 37105108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis.
    Adhami M; Sadeghi B; Rezapour A; Haghdoost AA; MotieGhader H
    BMC Biotechnol; 2021 Mar; 21(1):22. PubMed ID: 33711981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?
    Saha S; Halder AK; Bandyopadhyay SS; Chatterjee P; Nasipuri M; Bose D; Basu S
    Methods; 2022 Jul; 203():564-574. PubMed ID: 34455072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Network-based drug repurposing for the treatment of COVID-19 patients in different clinical stages.
    Wang X; Wang H; Yin G; Zhang YD
    Heliyon; 2023 Mar; 9(3):e14059. PubMed ID: 36855680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform.
    Hwang W; Han N
    Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico drug repurposing against SARS-CoV-2 using an integrative transcriptomic profiling approach: Hydrocortisone and Benzhydrocodone as potential drug candidates against COVID-19.
    Mirmohammadi S; Kianmehr A; Sabbaghian A; Mohebbi A; Shahbazmohammadi H; Sheykharabi M; Bazzi Z
    Infect Genet Evol; 2022 Sep; 103():105318. PubMed ID: 35718334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
    Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
    Zhou Y; Hou Y; Shen J; Huang Y; Martin W; Cheng F
    Cell Discov; 2020; 6():14. PubMed ID: 32194980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates.
    Rodrigues L; Bento Cunha R; Vassilevskaia T; Viveiros M; Cunha C
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
    Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
    Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
    Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
    Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19.
    Stolfi P; Manni L; Soligo M; Vergni D; Tieri P
    Front Cell Dev Biol; 2020; 8():545089. PubMed ID: 33123533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection.
    Mousavi SZ; Rahmanian M; Sami A
    Infect Genet Evol; 2020 Dec; 86():104610. PubMed ID: 33130005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking.
    K C M; K A AN
    Comb Chem High Throughput Screen; 2022; 25(12):2089-2102. PubMed ID: 35142268
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
    Gates LE; Hamed AA
    J Med Internet Res; 2020 Aug; 22(8):e21169. PubMed ID: 32735546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Repurposing for the Treatment of COVID-19: A Knowledge Graph Approach.
    Yan VKC; Li X; Ye X; Ou M; Luo R; Zhang Q; Tang B; Cowling BJ; Hung I; Siu CW; Wong ICK; Cheng RCK; Chan EW
    Adv Ther (Weinh); 2021 Jul; 4(7):2100055. PubMed ID: 34179346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.